Skip to main content

Peer Review reports

From: Humanized CD19 CAR-T cells in relapsed/refractory B-ALL patients who relapsed after or failed murine CD19 CAR-T therapy

Original Submission
23 Jan 2022 Submitted Original manuscript
22 Feb 2022 Reviewed Reviewer Report
23 Feb 2022 Reviewed Reviewer Report
13 Mar 2022 Author responded Author comments - Shuangyou Liu
Resubmission - Version 2
13 Mar 2022 Submitted Manuscript version 2
20 Mar 2022 Reviewed Reviewer Report
28 Mar 2022 Reviewed Reviewer Report
Resubmission - Version 3
Submitted Manuscript version 3
Publishing
4 Apr 2022 Editorially accepted
12 Apr 2022 Article published 10.1186/s12885-022-09489-1

You can find further information about peer review here.

Back to article page